These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27333656)

  • 1. [Effectiveness of N-acetylcysteine in the treatment of schizophrenia].
    Miyake N; Miyamoto S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2016 Apr; 36(2):29-35. PubMed ID: 27333656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats.
    Choy KH; Dean O; Berk M; Bush AI; van den Buuse M
    Eur J Pharmacol; 2010 Dec; 649(1-3):224-8. PubMed ID: 20868666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of cognitive function in schizophrenia with
    Yolland COB; Phillipou A; Castle DJ; Neill E; Hughes ME; Galletly C; Smith ZM; Francis PS; Dean OM; Sarris J; Siskind D; Harris AWF; Rossell SL
    Nutr Neurosci; 2020 Feb; 23(2):139-148. PubMed ID: 29847303
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview on the Effects of
    Tardiolo G; Bramanti P; Mazzon E
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30551603
    [No Abstract]   [Full Text] [Related]  

  • 5. N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.
    Minarini A; Ferrari S; Galletti M; Giambalvo N; Perrone D; Rioli G; Galeazzi GM
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):279-292. PubMed ID: 27766914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial.
    Klauser P; Xin L; Fournier M; Griffa A; Cleusix M; Jenni R; Cuenod M; Gruetter R; Hagmann P; Conus P; Baumann PS; Do KQ
    Transl Psychiatry; 2018 Oct; 8(1):220. PubMed ID: 30315150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review.
    Sadowska AM; Manuel-Y-Keenoy B; De Backer WA
    Pulm Pharmacol Ther; 2007; 20(1):9-22. PubMed ID: 16458553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A minireview on N-acetylcysteine: An old drug with new approaches.
    Elbini Dhouib I; Jallouli M; Annabi A; Gharbi N; Elfazaa S; Lasram MM
    Life Sci; 2016 Apr; 151():359-363. PubMed ID: 26946308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status.
    Zhou J; Coles LD; Kartha RV; Nash N; Mishra U; Lund TC; Cloyd JC
    J Pharm Sci; 2015 Aug; 104(8):2619-26. PubMed ID: 26052837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation pathway and exacerbations in COPD: the role of NAC.
    Matera MG; Calzetta L; Cazzola M
    Expert Rev Respir Med; 2016; 10(1):89-97. PubMed ID: 26567752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in rats.
    Smaga I; Pomierny B; Krzyżanowska W; Pomierny-Chamioło L; Miszkiel J; Niedzielska E; Ogórka A; Filip M
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):280-7. PubMed ID: 22820675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation.
    Lanté F; Meunier J; Guiramand J; De Jesus Ferreira MC; Cambonie G; Aimar R; Cohen-Solal C; Maurice T; Vignes M; Barbanel G
    Hippocampus; 2008; 18(6):602-9. PubMed ID: 18306297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ; Pande M; Kannan GM; Mehta A
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
    Conus P; Seidman LJ; Fournier M; Xin L; Cleusix M; Baumann PS; Ferrari C; Cousins A; Alameda L; Gholam-Rezaee M; Golay P; Jenni R; Woo TW; Keshavan MS; Eap CB; Wojcik J; Cuenod M; Buclin T; Gruetter R; Do KQ
    Schizophr Bull; 2018 Feb; 44(2):317-327. PubMed ID: 29462456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials.
    Zheng W; Zhang QE; Cai DB; Yang XH; Qiu Y; Ungvari GS; Ng CH; Berk M; Ning YP; Xiang YT
    Acta Psychiatr Scand; 2018 May; 137(5):391-400. PubMed ID: 29457216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards stage specific treatments: effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia.
    Rapado-Castro M; Berk M; Venugopal K; Bush AI; Dodd S; Dean OM
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():69-75. PubMed ID: 25315856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Neuroprotective Potential of N-Acetylcysteine for Prevention and Treatment of Cognitive Aging and Dementia.
    Hara Y; McKeehan N; Dacks PA; Fillit HM
    J Prev Alzheimers Dis; 2017; 4(3):201-206. PubMed ID: 29182711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study.
    Farokhnia M; Azarkolah A; Adinehfar F; Khodaie-Ardakani MR; Hosseini SM; Yekehtaz H; Tabrizi M; Rezaei F; Salehi B; Sadeghi SM; Moghadam M; Gharibi F; Mirshafiee O; Akhondzadeh S
    Clin Neuropharmacol; 2013; 36(6):185-92. PubMed ID: 24201233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrotic and antioxidant effects of N-acetylcysteine in an experimental cholestatic model.
    Galicia-Moreno M; Favari L; Muriel P
    Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):179-85. PubMed ID: 22241216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on the possible molecular mechanism of action of N-acetylcysteine against insulin resistance and type-2 diabetes development.
    Lasram MM; Dhouib IB; Annabi A; El Fazaa S; Gharbi N
    Clin Biochem; 2015 Nov; 48(16-17):1200-8. PubMed ID: 25920891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.